These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17700685)

  • 1. Parkinson's disease: pro-survival effects of PINK1.
    Abeliovich A
    Nature; 2007 Aug; 448(7155):759-60. PubMed ID: 17700685
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
    Büeler H
    Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling.
    Rüb C; Schröder N; Voos W
    Biochem Soc Trans; 2015 Apr; 43(2):287-91. PubMed ID: 25849931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease: Mitochondrial damage control.
    Abeliovich A
    Nature; 2010 Feb; 463(7282):744-5. PubMed ID: 20148026
    [No Abstract]   [Full Text] [Related]  

  • 5. PINK1 activation-turning on a promiscuous kinase.
    Aerts L; De Strooper B; Morais VA
    Biochem Soc Trans; 2015 Apr; 43(2):280-6. PubMed ID: 25849930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
    Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
    Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial cell death control in familial Parkinson disease.
    Kroemer G; Blomgren K
    PLoS Biol; 2007 Jul; 5(7):e206. PubMed ID: 17638420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PINK1 in mitochondrial function.
    Plun-Favreau H; Hardy J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11041-2. PubMed ID: 18687903
    [No Abstract]   [Full Text] [Related]  

  • 11. Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling.
    Kim KH; Song K; Yoon SH; Shehzad O; Kim YS; Son JH
    J Biol Chem; 2012 Dec; 287(53):44109-20. PubMed ID: 23144451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A little bit of PINK in Parkinson's disease].
    Berthier A
    Med Sci (Paris); 2008 Feb; 24(2):118-9. PubMed ID: 18272063
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease.
    Blackinton JG; Anvret A; Beilina A; Olson L; Cookson MR; Galter D
    Brain Res; 2007 Dec; 1184():10-6. PubMed ID: 17950257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative disease: pink, parkin and the brain.
    Pallanck L; Greenamyre JT
    Nature; 2006 Jun; 441(7097):1058. PubMed ID: 16810237
    [No Abstract]   [Full Text] [Related]  

  • 15. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
    Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
    J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease.
    Calabresi P; Ghiglieri V
    Mov Disord; 2014 Jan; 29(1):11-4. PubMed ID: 24357533
    [No Abstract]   [Full Text] [Related]  

  • 17. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
    Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
    Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of heat shock proteins in Parkinson's disease.
    Aridon P; Geraci F; Turturici G; D'Amelio M; Savettieri G; Sconzo G
    Neurodegener Dis; 2011; 8(4):155-68. PubMed ID: 21212626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PINK1 targets dysfunctional mitochondria for autophagy in Parkinson disease.
    Jones N
    Nat Rev Neurol; 2010 Apr; 6(4):181. PubMed ID: 20383881
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease.
    Abahuni N; Gispert S; Bauer P; Riess O; Krüger R; Becker T; Auburger G
    Neurosci Lett; 2007 Mar; 414(2):126-9. PubMed ID: 17267121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.